Security
Translational Development Acquisition Corp. Ordinary Shares · TDAC
TDACNASDAQCommon stockCurrentCIK 1926599Updated Nov 2, 2026
TDAC price & chart
Loading TradingView…
NASDAQ:TDAC on TradingView ↗About the company
The Company is a blank check company incorporated for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company may pursue an acquisition opportunity in any business, industry, sector, or geographical location, and intends to focus on industries that complement its management team's background, and intends to capitalize on the ability of its management team to identify and acquire a business.
In the news
TDAC Announces ProLogium's Filing of F-4 As Continuing Momentum Towards Merger ↗
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Translational Development Acquisition Corp. (NASDAQ: TDAC) ↗
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Translational Development Acquisition Corp. (NASDAQ: TDAC) ↗
SEC disclosures
Prologium Holding Inc. files merger communication (425) ↗
Recent filings
10-Q filing
SCHEDULE 13G - filed by METEORA CAPITAL, LLC regarding Translational Development Acquisition Corp.
SCHEDULE 13G/A - filed by Linden Capital L.P. regarding Translational Development Acquisition Corp.
425 filing
Entry into a Material Definitive Agreement · Unregistered Sales of Equity Securities
Items 1.01, 3.02, 9.01
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| AssetsUSD | 179,979,659Source | — | 157,366,598Source | 178,181,374Source | — | 183,346,585Source | 176,596,250Source | — | 181,696,776Source | 175,000,579Source | 2,021Source |
| Current assets: | |||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 47,150Source | — | 85,877Source | 35,255Source | — | 24,630Source | 206,600Source | — | 29,787Source | 438,174Source | 2,021Source |
| Assets, CurrentUSD | 80,582Source | — | 104,731Source | 156,077Source | — | 75,316Source | 415,422Source | — | 39,465Source | 650,233Source | 2,021Source |
| LIABILITIES AND EQUITY | |||||||||||
| LiabilitiesUSD | 6,460,345Source | — | 7,789,050Source | 6,322,182Source | — | 6,898,585Source | 6,360,400Source | — | 6,581,573Source | 6,247,803Source | 509,679Source |
| Stockholders’ equity: | |||||||||||
| Additional Paid in CapitalUSD | — | — | — | — | — | — | — | — | — | — | 24,534Source |
| Retained Earnings (Accumulated Deficit)USD | -6,380,229Source | — | -7,684,785Source | -6,166,571Source | — | -6,823,735Source | -5,945,444Source | — | -6,542,574Source | -5,598,036Source | -532,658Source |
| Stockholders' Equity Attributable to ParentUSD | -6,379,763Source | -570,626Source | -7,684,319Source | -6,166,105Source | -509,343Source | -6,823,269Source | -5,944,978Source | -507,658Source | -6,542,108Source | -5,597,570Source | -507,658Source |
| Liabilities and EquityUSD | 179,979,659Source | — | 157,366,598Source | 178,181,374Source | — | 183,346,585Source | 176,596,250Source | — | 181,696,776Source | 175,000,579Source | 2,021Source |
| Current liabilities: | |||||||||||
| Liabilities, CurrentUSD | 422,845Source | — | 1,751,550Source | 284,682Source | — | 861,085Source | 322,900Source | — | 544,073Source | 210,303Source | 509,679Source |
| Accounts Payable, CurrentUSD | — | — | — | — | — | — | — | — | — | 16,189Source | 1,252Source |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | — | — | — | 1,332,797Source | 1,483,074Source | 6,362,427Source | -71,012Source | -485,550Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -305,157Source | -231,574Source | -608,387Source | -851,446Source | -204Source |
| Cash flows from investing activities: | |||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | — | — | — | -174,225,000Source | — |
| Cash flows from financing activities: | |||||||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 300,000Source | — | 200,000Source | 175,512,599Source | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 47,150Source | 224,038Source | 85,877Source | 35,255Source | 24,630Source | 206,600Source | 29,787Source | 438,174Source | 2,021Source |
| Additional Financial Items | |||||||||||
| General and Administrative ExpenseUSD | — | — | 213,658Source | 61,283Source | 661,050Source | 221,127Source | 281,161Source | 347,408Source | 944,538Source | — | — |
| Income Tax Expense (Benefit)USD | — | — | — | — | — | — | 0Source | 0Source | — | 0Source | — |
| Marketable Securities, Unrealized Gain (Loss)USD | — | — | — | — | -36,138Source | — | 1,613,958Source | 1,830,482Source | 7,306,965Source | 125,346Source | — |
| Net Income (Loss) Attributable to ParentUSD | — | — | 1,660,122Source | -61,283Source | 946,982Source | 1,623,342Source | 1,332,797Source | 1,483,074Source | 6,362,427Source | -71,012Source | -485,550Source |
| Nonoperating Income (Expense)USD | — | — | 1,873,780Source | — | 1,608,032Source | 1,844,469Source | 1,613,958Source | 1,830,482Source | 7,306,965Source | 125,346Source | — |
| Payments to Acquire InvestmentsUSD | — | — | — | — | — | — | — | — | — | 174,225,000Source | — |
| Marketable Securities, Gain (Loss), Excluding Other-than-temporary Impairment Loss | — | — | — | — | — | — | — | —Source | — | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating Income (Loss) | — | — | —Source | —Source | —Source | —Source | —Source | —Source |
| Income Tax Expense (Benefit) | — | — | — | — | — | — | —Source | —Source |
| Net Income (Loss) Attributable to Parent | — | — | —Source | —Source | —Source | —Source | —Source | —Source |
| General and Administrative Expense | — | — | —Source | —Source | —Source | —Source | —Source | —Source |
| Nonoperating Income (Expense) | — | — | —Source | — | —Source | —Source | —Source | —Source |
Filing attachments
tm2619975d1_ex99-1.htm · 8-K · 2026-07-08
EX-99.1 2 tm2619975d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 TDAC Announces ProLogium’s Filing of F-4 As Continuing Momentum Towards Merger NEW YORK, NY - July 6, 2026 - Translational Development Acquisition Company (NYSE: TDAC) ( “TDAC”) announced that ProLogium has filed their initial F-4 with the SEC driving the companies forward towards a successful execution of the de-SPAC transaction. This filing gives the SEC and investors at large a fuller view into the history of ProLogium and furt…
Read attachment ↗tm2618552d1_ex99-1.htm · DEFA14A · 2026-06-23
Exhibit 99.1 TDAC Announces Very Successful Share Redemption Results in Connection with Extension Vote 85% of Shares are not Redeemed, resulting in TDAC maintaining $156.8mm in trust 95% of the Shares Voted Were In Favor of the Extension These Great Results Follow the Momentum of the May 27, 2026 announcement of TDAC’s Entry into a Merger Agreement with Prologium ───────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────…
Read attachment ↗tm2618552d1_ex99-1.htm · 425 · 2026-06-23
Exhibit 99.1 TDAC Announces Very Successful Share Redemption Results in Connection with Extension Vote 85% of Shares are not Redeemed, resulting in TDAC maintaining $156.8mm in trust 95% of the Shares Voted Were In Favor of the Extension These Great Results Follow the Momentum of the May 27, 2026 announcement of TDAC’s Entry into a Merger Agreement with Prologium ───────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────…
Read attachment ↗tm2618552d1_ex99-1.htm · 8-K · 2026-06-23
EX-99.1 2 tm2618552d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 TDAC Announces Very Successful Share Redemption Results in Connection with Extension Vote 85% of Shares are not Redeemed, resulting in TDAC maintaining $156.8mm in trust 95% of the Shares Voted Were In Favor of the Extension These Great Results Follow the Momentum of the May 27, 2026 announcement of TDAC’s Entry into a Merger Agreement with Prologium ─────────────────────────────────────────────────────────────────────────…
Read attachment ↗tm2615602d1_ex99-1.htm · 425 · 2026-05-27
Exhibit 99.1 ProLogium, a Next Generation Solid-State Battery Developer with 10+ Years of Proven Commercialization, to List on the Nasdaq through a Merger with Translational Development Acquisition Corp. ProLogium reached commercial-scale manufacturing for solid-state batteries in 2013, later delivered the world’s first solid-state battery demo car with ENOVATE Motor in 2019. ProLogium has shipped a total of over 2.4 million battery cells to customers since 2013, of which more than 80…
Read attachment ↗tm2615602d1_ex99-2.htm · 425 · 2026-05-27
Exhibit 99.2 1 Investor Presenta t ion M a y 2 0 26 2 Di s cl a imer T h is do c u m en t c o n t a i n s c o n fi d en ti a l i n f o r m a ti o n regard i n g P r o l o g i u m H o l d i n g I n c. ( t h e “ C o m pan y ” ), T ran sl a ti o na l D e v e l o p m en t Ac qu isiti o n C o rp. ( “ T DAC ” ) and t h e i r re s p e c t iv e s u b si d i a r i e s, s h areh o l der s and a s s o ci a t e d under t a ki n g s and t h e i r bu si n e s s e s. T h is pre s e n t a ti o n ha s been pre…
Read attachment ↗